Italia markets closed

United-Guardian, Inc. (UG)

NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
11,75+0,07 (+0,60%)
Alla chiusura: 04:00PM EST
11,99 +0,24 (+2,04%)
Dopo ore: 04:00PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente11,68
Aperto11,73
Denaro11,35 x 1000
Lettera13,59 x 800
Min-Max giorno11,58 - 11,75
Intervallo di 52 settimane10,12 - 26,09
Volume1.701
Media Volume5.281
Capitalizzazione53,983M
Beta (5 anni mensile)0,49
Rapporto PE (ttm)18,08
EPS (ttm)0,65
Prossima data utili15 mar 2023 - 20 mar 2023
Rendimento e dividendo (forward)0,68 (6,10%)
Data ex dividendo25 nov 2022
Stima target 1AN/D
  • GlobeNewswire

    United-Guardian Declares Year-End Dividend

    HAUPPAUGE, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on November 15, 2022, declared a cash dividend of $0.31 per share, which will be paid on December 7, 2022 to all stockholders of record on November 28, 2022. Beatriz Blanco, President of United-Guardian, stated, “We are pleased to once again be in a position to pay a year-end dividend to our stockholders, despite the continuing impact the glob

  • GlobeNewswire

    United-Guardian Reports Third Quarter Financial Results

    HAUPPAUGE, N.Y., Nov. 09, 2022 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported today that net income for the third quarter of 2022 decreased from $1,016,506 ($0.22 per share) in 2021 to $345,518 ($0.07 per share) in this year’s third quarter. Net sales for the quarter decreased from $3,179,746 to $2,417,022. For the nine-month period ended September 30th net income decreased from $3,542,232 ($0.77 per share) in 2021 to $1,890,307 ($0.41 per share) this year, and net sales decrease

  • GlobeNewswire

    United-Guardian Announces Appointment of New President & CEO

    HAUPPAUGE, N.Y., Oct. 25, 2022 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ: UG), a manufacturer of cosmetic ingredients, pharmaceuticals, medical and health care products, and specialty chemicals, announced today that the company’s Board of Directors has appointed Beatriz Blanco the company’s next President and Chief Executive Officer. Ms. Blanco will also be joining the company’s Board of Directors. She succeeds Ken Globus, the company’s current President & CEO, who will be retiring after